You brought this type of action to my attention Van. And since I have seen two of these! I think it's anew trick to get the Meme crowd- BlueLinx terminates 'at-the-market' equity offering program 16:28 BXC BlueLinx Holdings announced the termination of its "at-the-market" equity offering program with Jefferies as sales agent. The company elected to terminate the ATM Offering given its ample liquidity and to limit uncertainty and unfavorable dilution for its shareholders. The company initiated the 10-trading day termination process of the ATM Offering with Jefferies, with the official termination taking effect on September 2. The company will make no sales under the ATM Offering during this 10-trading day window. No shares were sold under the ATM Offering, and, upon termination, the company will have no further obligations related to the ATM Offering.
Gevo initiated with a Buy at Stifel 16:09 GEVO Matterport initiated with an Outperform at Credit Suisse 16:02 MTTR Credit Suisse analyst John Walsh initiated coverage of Matterport with an Outperform rating and $20 price target. TaskUs, Inc. (TASK)- Did you see I nailed the Top Van! -TopTick NasdaqGS - NasdaqGS Real Time Price. Currency in USD $48.75-0.67 (-1.36%) At close: 4:00PM EDT BABA went positive Van was neg-- Powerful chart pattern! --
What the hell has happened to this company Van!--Abbot management implodes. As the COVID-19 cases dropped in the spring, Abbott (ABT-0.2%) had taken steps to shred millions of its rapid COVID-19 tests at a manufacturing site in Maine, The New York Times reported. The company also canceled supplier contracts and closed the only other plant in Illinois tasked with making the test, leading to the dismissal of 2,000 workers. However, as people return to schools and offices while COVID-19 is making a comeback in the U.S., the demand for the popular rapid antigen tests called BinaxNOW is rising once again. But this time, the company is scrambling to rehire hundreds of workers, and struggling to ramp up production. According toThe Times, CVS(NYSE:CVS), Rite Aid(NYSE:RAD), and Walgreens(NASDAQ:WBA)are all selling out of the at-home test, and the deliveries from Amazon(NASDAQ:AMZN)for the test can get delayed up to three weeks. Meanwhile, Abbott(NYSE:ABT)and the rival Quidel(NASDAQ:QDEL)traded lower when Bloomberg cited issues with the companies’ COVID-19 tests. What name do you not see on that list? OraSure also selling at home tests-- their sales must be WAY UP!<---- OSUR- On the way to $14!<------- OraSure Technologies, Inc. $10.50
IMAX A TAKEOUT! YES I AGREE!!! IMAX gains 3% as B. Riley singles it out for M&A upside Aug. 23, 2021 11:58 AM ETIMAX Corporation (IMAX)MasterCraft Boat Holdings, Inc. (MCFT)Gaia, Inc. (GAIA)Chicken Soup for the Soul Entertainment, Inc. (CSSE) IMAXisup 2.8%after B. Riley FBR floats the name as a candidate for acquisition, or a takeover by private equity. It's one of a few candidates that analyst Eric Wold has put together - including MasterCraft Boat Holdings (MCFT+0.6%), digital video subscription service Gaia (GAIA+4.5%) and Chicken Soup for the Soul Entertainment (CSSE-1.6%). They're all some 27% to 58% off their 52-week highs, and have some solid growth prospects coming out of the COVID-19 pandemic, as well as solid, mostly debt-free balance sheets and attractive valuation, he says. IMAX-$15<--- CHEAP!
Chewy is no slam dunk to nab major pet prescription market share - Needham Aug. 23, 2021 11:47 AM ET Chewy, Inc. (CHWY) Needham warns of some obstacles for Chewy(NYSE:CHWY)as it looks to land millions in pharmacy sales. The firm warns that vets have a foothold on the market and the pet population is plateauing based on vaccination data. Analyst Anna Andreeva notes that the vet channel still controls 70% of the U.S. Rx market distribution and has been seeing profitability erode given disruptive new entrants in the space, which could prompt vets to become competitive. "$2B in services can't leave the vet and aren't attainable to online players (vaccines, antibiotics, and dermatology). As such, capturing a larger size of the Rx market quickly from here isn't a slam dunk and may entail setting up partnerships with vets so that incentives are better aligned (as of 2Q21, 1/3 of US vet clinics have partnered with Covetrus who helps vets set up their own online stores)." Needham thinks the path to achieving the next leg of growth for CHWY could take a different form and likely entail a partnership with vets where economic models would be better aligned. The firm keeps a Hold rating on Chewy (CHWY)
Stoney!!!!!!! 88M shares traded today and your trusty business partner and loyal tennis friend VZ damn near bottom ticked it with his whopping 50 shares. Missed it by $0.70. Not bad. I'm holding on for now. TBH I think it'll pull back again. I might even close here in the after hours. I don't trust this market. There's our boy Riley again Stoney! Remember last week(?)... he's the one with the 10% divy that bought $8M worth of his own shares. That damn thing closed at $65 today.
Van have you heard about the third thumb? Yea it's real. It was invented about 4 years ago and recently perfected. The Dr Frankenstein here; "the creator" of the third thumb is worried that in the future a job like AMAZON might FORCE their workers to either wear a third thumb... lift more, lift faster... better at the computer too... Can hold those tablets while working!!!<---Or even freakier this proof of concept.. controlling a third thumb with your feet impulses- it can lead to a spare set of arms being mandatory at some UPS job... Don't forget your X-tra arms... Twice the work... one human. Is this a natural revolt against robots? Or something darker?
This is a company I back. Myomo. It can't get out of it's own way but it's product is great for mankind. That's why I'm a shareholder. Shouldn't Boston Scientific buy these guys?
Lets watch this sleepy bastard- Tile Shop Holdings, Inc. (TTSH)- Still think there's a move here someday... NasdaqCM - NasdaqCM Real Time Price. Currency in USD $7.73+0.41 (+5.60%)<---------- At close: 4:00PM EDT Right at 1 month break out point<----